Mark E McDonnell

This inventor holds 53 USPTO granted patents and 10 published patent applications and 5 EPO patents, primarily in Drug Development (CPC class C07D). Top assignees: Janssen Pharmaceutica Nv, The Wistar Institute, Biohaven Pharmaceutical Holding Company Limited. Active years: 2001-2025.

USPTO Granted Patents = 53 (Patent Applications = 10)

% Patents Active = 79.2

EPO Patents = 5 (Patent Applications = 12)

Average Co-Inventor Count = 7.4

ph-index = 8

Forward Citations = 406(Granted Patents)

Forward Citations (Not Self Cited) = 362(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Raritan, NJ (US) (2001)
Lansdale, PA (US) (2006 - 2024)

Company Filing History:

34 out of 2,099

Janssen Pharmaceutica Nv

Biohaven Pharmaceutical Holding Company Limited

patents

4. 4 out of 1,492

Rutgers, The State University of New Jersey

Kannalife Sciences, Inc.

patents

7. 2 out of 363

Ortho-Mcneil Pharmaceutical Corp.

patents

where one patent can have more than one assignee

Years Active: 2001-2025

Loading Chart...

Areas of Expertise:

EBNA1 Inhibitors

Prodrugs of Riluzole

Monoacylglycerol Lipase Inhibitors

Tau Oligomers

Functionalized Benzene Diols

Heteroaromatic Compounds

Azetidinyl Diamides

Vanilloid VR1 Receptor

Tricyclic Opioid Modulators

Quinazolinones

Piperazinyl Amides

Oxopiperazine Compounds

53 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12331043 - Benzofuran, benzothiophene, and indole analogs that inhibit the formation of tau oligomers and their method of use (2025-06-17),

2. 12258314 - EBNA1 inhibitors and their method of use (2025-03-25),

3. 12172974 - Prodrugs of riluzole and their method of use (2024-12-24),

4. 11912659 - EBNA1 inhibitors and methods using same (2024-02-27),

5. 11472776 - Quinazolinones that inhibit the formation of tau oligomers and their method of use (2022-10-18),

6. 11440893 - Prodrugs of riluzole and their method of use (2022-09-13),

7. 11306075 - Benzofuran, benzothiophene, and indole analogs that inhibit the formation of tau oligomers and their method of use (2022-04-19),

8. 11242317 - EBNA1 inhibitors and their method of use (2022-02-08),

9. 10981867 - EBNA1 inhibitors and methods using same (2021-04-20),

10. 10844026 - Prodrugs of riluzole and their method of use (2020-11-24),

11. 10562870 - Prodrugs of riluzole and their method of use (2020-02-18),

12. 10442763 - EBNA1 inhibitors and methods using same (2019-10-15),

13. 10421718 - EBNA1 inhibitors and their method of use (2019-09-24),

14. 10004722 - Method for treating hepatic encephalopathy or a disease associated with free radical mediate stress and oxidative stress with novel functionalized 1,3-benzene diols (2018-06-26),

15. 9856214 - EBNA1 inhibitors and their method of use (2018-01-02),

Title: The Innovative Journey of Mark E McDonnell

Introduction: Mark E McDonnell, a talented inventor hailing from Lansdale, PA, has made significant contributions to the world of technology through his groundbreaking innovations.

Latest Patents: Mark E McDonnell's latest patents showcase his prowess in the field of technology, with a focus on advancements in artificial intelligence and renewable energy solutions.

Career Highlights: With a career spanning over two decades, Mark E McDonnell has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing innovative solutions to address them. His work has not only revolutionized industries but has also improved the lives of many around the globe.

Collaborations: Throughout his career, Mark E McDonnell has collaborated with leading tech companies, research institutions, and universities to bring his inventions to life. His ability to work seamlessly with teams of experts has been instrumental in the success of his projects.

Conclusion: Mark E McDonnell's passion for innovation, coupled with his dedication to pushing the boundaries of what is possible, has solidified his position as a respected inventor in the tech industry. His relentless pursuit of excellence continues to inspire future generations of inventors to think outside the box and create a better tomorrow.